PHOENIX, Feb. 08, 2018 -- India Globalization Capital, Inc. (NYSE American:IGC) (the “Company”) provides IGC operations update on Stock Day Podcast with Everett Jolly.
IGC has a legacy business in infrastructure focused primarily in India, Malaysia and Hong Kong. More recently the company has expanded into the Cannabis Pharmacy business, which will reach the United States and Canada.
“The diversification in IGC both geographically and by industry makes it an interesting investment,” said Jolly. “The cannabis industry is rapidly growing in the United States; the Company’s decision to direct their attention to one specific area of study, Alzheimer’s, will allow parallel penetration into the industry.”
Mukunda commented, “We are preparing to release our first product, Hyalolex, through dispensaries in the next several weeks. In parallel we are also pursuing a traditional FDA path that is in its pre-clinical phase. Our product is the result of many years of research and I look forward to the positive effects it will have on Alzheimer’s patients.”
To view the interview in its entirety, click here: https://upticknewswire.com/featured-interview-ceo-ram-mukunda-of-india-globalization-capital-inc-nasdaq-igc/
About IGC
IGC has two lines of business, a legacy infrastructure and commodity trading business and a cannabis pharmaceutical business that has developed a lead product for treating Alzheimer’s patients. The Company recently announced that it is working on using blockchain to address issues specific to the cannabis industry including transactional difficulties, product labeling, product identification assurance (PIA), and product origin assurance (POA). The Company is based in Maryland, USA.
For more information please visit www.igcpharma.com
Follow us on Twitter @IGCIR and Facebook.com/IGCIR/
About Uptick Newswire and the “Stock Day Podcast”
Uptick Newswire is a private company reaching out to the masses keeping investors and shareholders up to date on company news and bringing transparency to the undervalued, undersold, micro-cap stocks of the market and is the sole producer of the Uptick Network “Stock Day” Podcast. The Uptick Network “Stock Day” Podcast is an extension of Uptick.
Follow us and keep an eye on Uptick’s YouTube, Twitter, and Facebook for additional radio and video shows produced by Uptick! https://www.youtube.com/watch?v=kU5SVLp4org
Investors Hangout is a proud sponsor of Stock Day and Uptick Newswire encourages listeners to visit India Globalization Capital’s message board on: https://investorshangout.com/India-Globalization-Capital-Inc-IGC-56759/
Forward-looking Statements
Please see forward looking statements as discussed in detail in IGC's Form 10K for fiscal year ended March 31, 2017, and in other reports filed with the U.S. Securities and Exchange Commission.
Contact:
Claudia Grimaldi
301-983-0998
Source: Uptick Newswire


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



